| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |